The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition Strategy Update

1 Jul 2013 07:00

RNS Number : 2152I
Quindell Portfolio PLC
01 July 2013
 



Embargoed for release at 7.00am 1 July 2013

 

Quindell Portfolio Plc

("Quindell", the "Company" or the "Group")

 

Acquisition Strategy Update

 

Quindell Portfolio Plc (AIM: QPP.L), a leading provider of software, consultancy and technology enabled outsourcing services to the insurance, telecommunications and other related markets is pleased to provide an update on its acquisition strategy and to announce the acquisition of React and Recover Medical Group Limited ("React and Recover").

 

Highlights

 

·; Past acquisitions beating performance targets enabling early acceptance of performance warranties

·; Acquisition of tactical business to support growth in Quindell Health Services

·; Organic growth primary driver in 2013 and 2014

 

On 18 June 2013, the Group provided its first investor teach-in which covered its Acquisition, Integration and Overall Strategy. At this teach-in, the Group confirmed that acquisitions would represent a smaller part of its growth strategy in 2013 than was the case for 2012, and guided that acquisitions during the current financial year would typically be small relative to the size of the Group and likely to be of a tactical or in-fill nature.

 

As previously outlined in the Group's annual report and as guided in the recent teach-in, the Company's criteria for acquisitions can be summarised as:

 

- Only pursuing earnings enhancing opportunities that have already been de-risked by working closely with the business prior to acquisition, and where significant synergistic growth is available

- Typically paying five to seven times profit after tax with a 12 month future warranted profit and cash generation targets, with claw backs if these warranted targets are not met

- Only issuing stock in respect of acquisitions at the greater of a 20% premium to current trading price or 17.5 pence, with the consideration stock locked-in for between 12 and 36 months and subject to orderly market restrictions

 

As a result of strong trading performance by historic acquisitions, the Board anticipates reviewing and reaching agreement with vendors on the acceptance of post acquisition warranty obligations for certain businesses within Quindell Health Services (part of its Services Division) as it is clear that these businesses have been operating at a run rate that demonstrates that those obligations will be met ahead of expectations. This early agreement will enable further integration and efficiencies to be obtained for the benefit of the Group in the current financial year.

 

As one of its identified tactical acquisitions, the Group is pleased to announce the acquisition of accident rehabilitation and medical reporting specialists React and Recover on 28 June 2013. The terms of the acquisition were satisfied by the issue of 70,714,286 Quindell shares at an assumed price of 17.5 pence per share and the payment of £625,000 in cash. The shares, representing approximately 1.7% of the Group's issued share capital, will be subject to share lock in of between 12 and 36 months from the date of issue and orderly market restrictions. The companies acquired will warrant profit after tax of £2 million and generated cash flow of £1.5 million over an assessment period of 1 January 2013 to 31 December 2013. The acquisition is immediately earnings enhancing for the Group and will enable the Group to deliver further on the scale of business and opportunities within Quindell Health Services.

 

Looking ahead to 2014, the Group anticipates that whilst acquisitions would still be considered, management believe that between 10-20% of the Group's growth relative to 2013 would be by acquisition and approximately 80-90% of the year-on-year growth would be generated organically.

 

Copies of the Group's presentation from the first investor teach-in are available from the investors section of the Company's website www.quindell.com.

 

Rob Terry, Founder and Executive Chairman of Quindell said: "The Group has already delivered a significant amount of organic growth, and we expect this to continue throughout 2013 and beyond. The acquisition of React and Recover further enhances our ability to service this growth and our ability to deliver our outsource proposition to the UK insurance sector. The fact that our previous acquisitions are delivering on their warranted performance to the extent that we can now agree to accept their warranted performance as completed is very positive news and enables the Group to complete the full integration of these businesses ahead of schedule."

 

Application has been made for the 70,714,286 new shares to be admitted to trading on AIM. Admission of the shares is expected to occur on 5 July 2013. Following Admission Quindell will have 4,137,568,768 ordinary shares in issue. The Company has no ordinary shares held in treasury. The total of 4,137,568,768 ordinary shares may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

For further information:

 

Quindell Portfolio PlcRob Terry, Founder and Executive Chairman

 

Laurence Moorse, Group Finance Director

 

Ian Farrelly, Group General Counsel & Company Secretary

Head of Investor Relations

Tel: 01489 864201

terryr@quindell.com

Tel: 01489 864205

moorsel@quindell.com

Tel: 01489 864217

farrellyi@quindell.com

 

Cenkos Securities plcNominated Adviser and BrokerStephen Keys / Adrian Hargrave (Corporate Finance)

 

Tel: 020 7397 8900

 

Media EnquiriesRedleaf Polhill Limited

Rebecca Sanders-Hewett

Jenny Bahr

 

Tel: 020 7382 4730

quindell@redleafpr.com

 

About Quindell Portfolio Plc

 

Quindell Portfolio Plc is a provider of sector leading expertise in Software, Consulting and Technology Enabled Outsourcing in its key markets being Insurance, Telecommunications and their Related Sectors. Quindell joined the market through Mission Capital Plc on 17 May 2011. Quindell finished 2012 with run rate revenue of more than £300 million.

 

Our Industry Sectors

In today's digital world the line between traditional industry sectors continues to blur, however the focus on tight service management is common to them all. We believe that excellent customer service, tight cost control and integrated supply chain management is not the prerogative of any single industry sector and with our solutions in multiple industry sectors savings of over 20% against industry norms are being delivered to the bottom line.

 

Our Solutions

The pressures on an organisation can come simultaneously from multiple directions including the need to add customers, increase wallet share, reduce costs and improve customer satisfaction. At Quindell we have the People, the Processes and the Supply Chains, underpinned by our sophisticated Champion and Challenger Business Process Management Technology Platform and Industry Solutions to help our customers tackle these efficiently and effectively.

 

With a clear understanding that having the best products and services on offer is not always enough and that getting your customers to use or adopt them is key, effective conversion lies at the core of our unique Champion and Challenger tools and techniques. Using these solutions Quindell has helped its customers achieve sales and service conversion rates ranging from 75% to 90%, way above industry norms. But life does not stand still, and complacency can kill any business, so the embedded Champion and Challenger continual improvement focus of our Learning Solutions is at the heart of all we offer. Using our industry insight and expertise, Quindell takes the holistic view of our client's challenges.

 

For example, when considering the Insurance industry today where 50% of the cost of an auto claim is associated with Personal Injury, including legal services, medical reporting and rehabilitation, it is clear that an organisation will not be able to achieve the levels of savings and customer satisfaction desired without addressing the injury to the driver as well as the repair of the vehicle. This is why at Quindell we have designed our insurance solutions and supply chains to address the full end to end cycle, with the ability and expertise to treat an injured party as well as repairing their vehicle. This makes Quindell a truly unique and ethically based proposition for the insurance industry today.

 

Our Customers

Quindell Portfolio's companies have worked with over 2000 brands from Small to Medium Enterprises and Blue-chip organisations around the globe. Today we count a number of the world's top Insurance and Telecommunications blue chip companies within our client base, as well as hundreds of customer centric organisations working in both the distribution and supply of their services.

 

Our award winning Business Transformational, Software, Consulting and Outsourcing Solutions are recognised as delivering significant savings and additional sales to our customers every year.

 

For further information, please visit www.quindell.com

 

About React and Recover

React and Recover is a leader in the provision of accident rehabilitation services and medical reporting in the UK, incorporating React & Recover Medical Group Ltd, Medicalaw Limited, Recover Healthcare Limited, React Medical Reporting Limited and React Medical Management Limited. The business handles approximately 60,000 rehabilitation and reporting transactions per annum providing solicitors, insurers, employers, health carers and private clients with a comprehensive solution to rehabilitation.

 

For further information, please visit www.recoverhealthcare.com, www.medicalaw.com, www.reactmedical.co.uk

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQVBLFXXQFZBBE
Date   Source Headline
7th Jul 20217:00 amRNSCancellation - Watchstone Group PLC
6th Jul 20216:00 pmRNSWatchstone Group
5th Jul 20213:58 pmRNSForm 8.3 - Watchstone Group Plc
5th Jul 20212:05 pmRNSHolding(s) in Company
2nd Jul 20215:56 pmRNSHolding(s) in Company
2nd Jul 20215:09 pmRNSReplacement Form 8 (DD) - Watchstone Group plc
2nd Jul 20214:27 pmRNSHolding(s) in Company
2nd Jul 20212:03 pmRNSForm 8.3 - Watchstone Group Plc
2nd Jul 20211:45 pmGNWMan Group PLC : Form 8.3 - Watchstone Group plc
2nd Jul 202112:39 pmRNSForm 8 (DD) - Watchstone Group plc
2nd Jul 20217:05 amRNSForm 8 (OPD) Watchstone Group plc
1st Jul 20215:08 pmRNSRule 2.9 Announcement
1st Jul 20213:42 pmRNSOffer Update
1st Jul 20212:29 pmRNSForm 8 (DD) - Watchstone Group plc
1st Jul 20212:18 pmRNSOffer for Watchstone Group plc
29th Jun 202111:13 amRNSResult of AGM
24th May 20217:00 amRNSPublication of Accounts, Circular & Notice of AGM
7th May 202111:14 amRNSHolding(s) in Company
6th May 20217:00 amRNSFinal Results
6th May 20217:00 amRNSProposed Cancellation of Admission to AIM
4th May 20217:30 amRNSSuspension - Watchstone Group PLC
23rd Apr 20217:00 amRNSIntention to apply for admission to the AQSE
4th Feb 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20208:36 amRNSHolding(s) in Company
23rd Dec 202011:30 amRNSHolding(s) in Company
18th Dec 20208:22 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSDisposal
28th Oct 20209:38 amRNSResult of Meeting
12th Oct 20203:53 pmRNSHolding(s) in Company
8th Oct 20207:00 amRNSHolding(s) in Company
8th Oct 20207:00 amRNSProposed disposal of the Ingenie Business
29th Sep 20207:00 amRNSHalf-year Report
27th Aug 20207:00 amRNSHolding(s) in Company
7th Aug 202011:22 amRNSClaim against PricewaterhouseCoopers LLP
21st Jul 202010:46 amRNSSecond Share Premium Reduction & Return of Cash
24th Jun 20201:30 pmRNSResult of AGM
11th Jun 20205:52 pmRNSHolding(s) in Company
9th Jun 202011:00 amRNSFirst Share Premium Reduction & Return of Cash
29th May 20207:00 amRNSFurther Return of Cash, Accounts & Notice of AGM
28th May 20203:36 pmRNSHolding(s) in Company
15th May 202010:25 amRNSDirector/PDMR Shareholding
14th May 20201:06 pmRNSDirector/PDMR Shareholding
13th May 20207:00 amRNSFinal Results
28th Apr 20207:00 amRNSRegulatory update – No prosecution of the Company
27th Apr 202010:34 amRNSResult of Meeting
16th Apr 20204:47 pmRNSHolding(s) in Company
16th Apr 20201:39 pmRNSHolding(s) in Company
15th Apr 20209:07 amRNSHolding(s) in Company
9th Apr 20207:00 amRNSProposed Share Premium Reduction & Return of Cash
25th Mar 20209:30 amRNSUpdate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.